IN BRIEF: HeiQ to buy industrial biotechnology company Chrisal Belgium

HeiQ PLC - textiles technology firm - Signs agreement to acquire 51% of industrial biotechnology ...

Alliance News 3 March, 2021 | 2:22PM
Email Form Facebook Twitter LinkedIn RSS

HeiQ PLC - textiles technology firm - Signs agreement to acquire 51% of industrial biotechnology company Chrisal NV Belgium for EUR7.5 million. Notes EUR5.0 million is payable in cash and the remaining EUR2.5 million through the issue of 1.1 million shares by HeiQ. Says the acquisition is aligned with HeiQ's strategy of becoming "a global leader in materials innovation." On completion, Chrisal will be renamed HeiQ Chrisal.

"The acquisition of a majority stake in Chrisal brings multiple benefits to HeiQ and its shareholders. HeiQ Chrisal will provide us with revenue from other fast-growth markets adjacent to those we serve already, as well as exciting cross-selling opportunities for our and their existing core product range. The acquisition will progress our direct to consumer offer and enlarges our product offering to hygiene-sensitive environments, such as the healthcare sector," says Co-Founder & Chief Executive Carlo Centonze.

Current stock price: 212.10 pence, up 4.0% on Wednesday

Year-to-date change: up 18%

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
HeiQ PLC Ordinary Shares 8.88 GBX -0.88 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures